Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Scilex Holding Co. (SCLX)

Scilex Holding Co. (SCLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Scilex Holding Co. 960 SAN ANTONIO ROAD PALO ALTO CA 94303 USA

www.scilexholding.com Employees: 115 P: 650-516-4310

Sector:

Medical

Description:

Scilex Holding Company is a commercial biopharmaceutical company focused on developing and commercializing non-opioid therapies for patients with acute and chronic pain. Scilex Holding Company, formerly known as Vickers Vantage Corp. I, is based in PALO ALTO, Calif.

Key Statistics

Overview:

Market Capitalization, $K 68,949
Enterprise Value, $K 100,559
Shares Outstanding, K 8,491
Float, K 8,142
% Float 95.89%
Short Interest, K 185
Short Float 2.18%
Days to Cover 2.48
Short Volume Ratio 0.73
% of Insider Shareholders 4.11%
% of Institutional Shareholders 69.67%

Financials:

Annual Sales, $ 56,590 K
Annual Net Income, $ -72,810 K
Last Quarter Sales, $ 10,560 K
Last Quarter Net Income, $ -257,230 K
EBIT, $ -259,270 K
EBITDA, $ -254,910 K

Growth:

1-Year Return -31.99%
3-Year Return -97.22%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -22.17 on 11/14/25
Next Earnings Date 02/20/26
Earnings Per Share ttm -31.85
EPS Growth vs. Prev Qtr -198.79%
EPS Growth vs. Prev Year -252.26%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-35 on 04/15/25

SCLX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -249.89%
Profit Margin % -128.66%
Debt/Equity -0.25
Price/Sales 1.74
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -23.68
Interest Coverage -36.15
60-Month Beta 1.35
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar